2021 U-M Kellogg Eye Center Annual Report

Page 10

In it Together Two pairs of family members—one linked by blood, one by marriage—look to Kellogg for urgent glaucoma treatment

Glaucoma has been called the silent thief of sight. It can be inherited or result from other diseases, trauma, aging, or many other causes. Glaucoma can present at birth or develop late in life. Glaucoma’s hallmark characteristic, elevated intraocular pressure, can be manageable for years, and then spike rapidly At a high-volume referral center like Kellogg, our glaucoma experts expect to encounter these variations. But it’s not every day that they come along in pairs. Tierra and Makayla

Tierra Richardson, 25, and her sister Makayla Miller, 17, both of Grand

Rapids, Michigan, share an inherited form of glaucoma. Makayla’s glaucoma was discovered at birth,

MIDDLE OF THE SEMESTER MADE ME

ANXIOUS. BUT I WAS INTRIGUED WHEN

DR. SHAH DESCRIBED THE MIGS OPTION. BEING INVOLVED IN THE DECISION MADE

and surgery was performed on one of her eyes as an infant. Tierra was

ME FEEL MORE COMFORTABLE.

diagnosed at age six and underwent her

— Makayla Miller

first operation at age 16. In the ensuing years, both sisters’ intraocular pressures were watched closely, first by their local ophthalmologist, then by a Kellogg team led by glaucoma specialist Manjool Shah, M.D. “My glaucoma was well-monitored near home,” says

Elevated pressure was jeopardizing both of Tierra’s eyes. Dr. Shah performed cyclophotocoagulation on the eye that had undergone a prior surgery. The procedure applies laser energy to the part of the eye that produces intraocular fluid. That essentially ‘turns down the faucet,’ lowering eye pressure. Her other eye was a candidate for micro-

invasive glaucoma surgery, or MIGS. “We chose

to implant the XEN® gel stent, a flexible tube the size of an eyelash,” Dr. Shah explains. Kellogg was among the first U.S.

Tierra. “But I chose to travel to Kellogg for access to more

centers to implant this stent when it first earned FDA approval

options to keep my eye pressure down. I encouraged my mom,

in 2017.

who has lost much of her vision to glaucoma, to allow me to bring Makayla to Kellogg too.” At an evaluation in the spring of 2020, both Makayla

“At the time, I was a full-time college student,” Tierra recalls. “The thought of surgery in the middle of the semester made me anxious. But I was intrigued

and Tierra registered dangerously high intraocular pressures.

when Dr. Shah described the MIGS

“Both patients required prompt interventions,” recalls Dr. Shah.

option. Being involved in the decision

“Because of the distance they traveled, and despite the fact that

made me feel more comfortable.”

Kellogg was operating at limited capacity due to the pandemic,

Throughout the day, the sisters

we scheduled their procedures right away, arranging to operate

worried about each other. But Dr. Shah

on both sisters on the same day.”

kept each updated on the other’s prog-

Glaucoma had already cost Makayla virtually all of the vision in one eye. Dr. Shah recommended that a drainage tube be implanted to manage the pressure in the other eye. 8

Makayla Miller and her sister Tierra Richardson

THE THOUGHT OF SURGERY IN THE

and unpredictably.

ress. “We felt better knowing we were in it together,” says Makayla.


Turn static files into dynamic content formats.

Create a flipbook

Articles inside

Toward a Therapeutic Target for Proliferative Vitreoretinopathy

2min
page 25

State-of-the-Science Microscope Gives Kellogg Researchers New Edge

2min
page 25

Michigan Medicine to Establish Neural Engineering Training Program

2min
page 21

Endocrine Society Award

1min
page 21

Leading on the National Stage

2min
page 15

Marshall Parks Lecture at AAO

1min
page 13

Prioritizing Communication for Patient Safety

2min
page 13

New Faculty Members

3min
page 42

Alumni Highlights

4min
page 39

Recognizing Distinguished Alumni Richard Gutow, M.D., and Gary Gutow, M.D.

6min
pages 36-37

Guarding Photoreceptor Metabolism to Prevent Vision Loss in Inherited Retinal Diseases

2min
page 31

Big Data, Collaboration, and Impact

3min
page 35

A Visionary Legacy

3min
page 33

Eyes on the Future

3min
page 34

Kellogg’s Latest Heed Fellows

3min
page 32

U-M Learners Produce Online Newsletter

3min
page 29

Next-Generation Tools to Treat Abnormal New Ocular Blood Vessels

3min
page 28

Genetically-Modified Occludin Shown to Protect Against Diabetes-Related Vision Loss

2min
page 30

Innovation in Action

3min
page 24

New Pediatric Ophthalmology Fellowship in Ghana

3min
page 27

Kellogg Addresses Technician Shortage with Ongoing Training Program

2min
page 26

Kellogg Researcher Launches First of-its-Kind Study of Health and Aging in Kenya

2min
page 23

A New Regulator of Retinal Angiogenesis Discovered

2min
page 22

Lipid Droplets May Protect Against AMD

2min
page 20

Mapping the Genetic Landscape of Nanophthalmos

2min
page 19

Training Eye Disease Researchers in India

2min
page 18

Kellogg Leads International Team Linking Family’s Symptoms to Rare, Inherited Syndrome

4min
pages 14-15

Clinical Research Update: Patient Perspectives

4min
page 17

Finding New Pathways for the Treatment of Choroideremia

2min
page 16

Finding a Personalized Solution for Dry Eye

3min
page 12

Vitreoretinal Lymphoma: from Symptoms to Diagnosis to Treatment

5min
pages 4-5

In it Together

5min
pages 10-11

Collaborating to Deliver Specialized Care

3min
pages 8-9

Steno North American Fellowship

2min
page 5

The Chair’s Perspective

2min
page 3

Kellogg Offers Multiple Options for Limbal Stem Cell Deficiency

3min
page 7

COVID-19 Transmission Risk in Cornea Transplantation

2min
page 9

NIH-Funded Pilot Program Addresses Disparities in Glaucoma Care

3min
page 6
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.